INDEPENDENT REVIEW INTO UK CLINICAL TRIALS

Professor Atholl Johnston, President of the Clinical & Contract Research Association (CCRA), said in response to the announcement of this initiative, made by the Office of Life Sciences

“The CCRA greatly welcomes the review, announced last week, into commercial clinical trials in the UK. The review will be led by Lord James O’Shaughnessy and will address the worrying challenges that currently confront the industry. It is intended that the review will put forward recommendations that will restore the global competitiveness of the UK industry and support for NHS patients.

We look forward to working with Government and our colleagues, from all organisations in the field, to find solutions to the issues that are being faced, particularly by SME’s in the CRO industry. ”